Gene editing

#CRISPR #DNA #Gene editing #mRNA #Proteins #SCIEX

Gene therapy: The quest for cures requires analytics to keep up

This article is sponsored by SCIEX. A new era of medicine has entered clinics with drugs against sickle cell anaemia or gene-related deafness, and many more gene therapy drugs are in different stages of development. These novel approaches go beyond treating symptoms; they aim to cure diseases. However, the diversity… Read More

#News

Gene therapy
#Gene editing #Gene therapy #hepatitis #Phase I trial #Precision BioSciences

Precision hopes to cure chronic hepatitis B with gene editing

Precision BioSciences has announced it will commence a Phase I clinical trial for its in vivo gene editing programme PBGENE-HBV, following Clinical Trial Application (CTA) approval in Moldova. PBGENE-HBV is designed to cure chronic hepatitis B by eliminating cccDNA, the key source of replicating hepatitis B… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene editing #Gene therapy

Cell & Gene Therapy Showcase

In this free online event leading industry figures outline areas of opportunity in CGT drug discovery and development sector as well as highlighting challenges facing the industry and how they can be overcome. It features presentations from experts in the field of cell and gene therapy drug development as well… Read More

Webinar date:
Co-sponsored by Benchling, Sartorius, Applied StemCell, and Elegen Bio
#Webinars

RNA
#CRISPR #Gene editing #Genetics / genomics #Interview #RNA #University of Sydney

Beyond CRISPR – what a new tool offers gene editing

DDW Editor Reece Armstrong speaks to Dr Sandro Ataide, Senior Lecturer in Structural Biology at the School of Life and Environmental Sciences Sydney Drug Discovery Initiative (DDI). Earlier this year, Dr Ataide’s team developed a gene-editing tool called SeekRNA that uses a programmable ribonucleic acid (RNA) strand that can directly… Read More

#Exclusive Content

Neurons
#Ageing #CRISPR #Gene editing #Neuroscience #Regenerative Medicine #Stanford University

CRISPR gene editing reduces brain function decline with age

A new study has revealed that reducing the activity of a particular gene using CRISPR gene editing can rejuvenate stem cells in the brain to create fresh neurons. The finding in mice could open new avenues for potential therapeutics to improve brain function and reduce regenerative… Read More

#Editor's Choice #News

#CRISPR #Gene editing #Gene therapy #Genetic engineering #Genetics / genomics

New DDW Highlights episode: 8 July 2024

The latest episode of the DDW Highlights podcast and vodcast is now available to listen to or watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The last few days have seen some interesting developments… Read More

#News

#CRISPR #Gene editing #Gene therapy #Genetic engineering #Genetics / genomics

This week in drug discovery (1-5 July) 

News round-up for 1-5 July by DDW Senior Digital Content Editor Diana Spencer. The last few days have seen some interesting developments related to gene editing, including the discovery of a new mechanism for genetic programming and evidence in favour of redosing CRISPR-based therapies, as well as significant… Read More

#News

Genetic engineering RNA
#CRISPR #Gene editing #Genetic engineering #RNA #University of California

Beyond CRISPR: New mechanism for genetic programming discovered

A team of researchers have discovered the bridge recombinase mechanism, a precise and powerful tool to recombine and rearrange DNA in a programmable way. The study, published in Nature, reports their discovery of the first DNA recombinase that uses a non-coding RNA for sequence-specific selection of… Read More

#Editor's Choice #News

Research-lead-Dr-Sandro-Ataide-left-and-first-author-Rezwan-Siddiquee-with-Caitlin-McCormack-right
#CRISPR #Gene editing #Genetic engineering #University of Sydney

New gene-editing tool is more accurate than CRISPR

Scientists at the University of Sydney have developed a gene editing tool with greater accuracy and flexibility than CRISPR. SeekRNA uses a programmable ribonucleic acid (RNA) strand that can directly identify sites for insertion in genetic sequences, simplifying the editing process and reducing errors. Read More

#Editor's Choice #News

Cell and gene therapy
#FDA #Gene editing #Gene therapy #iECURE #In vivo #Paediatrics

FDA approves first in vivo gene insertion programme in infants

iECURE has been given the go-ahead to begin US trials of its investigational gene editing-based therapy in newborn males with neonatal onset Ornithine Transcarbamylase (OTC) deficiency. The Food and Drug Administration (FDA) Investigational New Drug (IND) clearance for ECUR-506 makes it the first in vivo gene… Read More

#Editor's Choice #News

CRISPR gene editing
#CRISPR #CRISPR-Cas9 #Gene editing #HPV #Immunotherapy #iPSC #Oncology

Discovery paves the way to ‘off-the-shelf’ cervical cancer therapy

Researchers from Japan have used CRISPR gene editing to enhance the effectiveness of rejuvenated cytotoxic T lymphocytes (rejTs) for targeted immunotherapy. RejTs constitute a promising approach for treating cervical cancer, though rejection by the host’s immune system is a major hurdle. In a recent… Read More

#Cancer Research #Editor's Choice #News

Gene editing concept
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

New eBook: What does the future hold for gene editing & CRISPR?

Following the first regulatory approval of a CRISPR-based drug in late 2023, over ten years since the CRISPR-Cas9 system was elucidated, there is considerable optimism about the future potential for gene editing technologies. The astonishing pace of innovation has led to new, potentially safer CRISPR-based techniques, including… Read More

#News

CRISPR eBook cover
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

Gene editing & CRISPR: Advances in applications and opportunity

This eBook explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future. Download this exclusive eBook to learn more about: How CRISPR is providing new solutions for common diseases; The potential of base editing… Read More

#DDW eBooks #Intelligence

Neurones in the brain
#Alzheimer's #Gene editing #Neurodegenerative disorders #Neuroscience

Advances in neuroscience drug discovery

Listen to this article on the DDW Podcast: Lu Rahman looks at neuroscience drug discovery – advances and challenges – and how breakthroughs in this field are helping address areas of unmet need.  Recent advances in biomarkers, research into the central nervous system and breakthroughs in human iPSC cell models, have bolstered… Read More

#Exclusive Content

#Eligo Bioscience #Funding #Gene editing #Genetics / genomics #Microbiome

Eligo raises $30 million to further gene editing within the microbiome

Gene editing company Eligo Bioscience has announced a successful $30 million Series B funding round, led by Sanofi Ventures. “We are excited to lead this financing for Eligo and support the company as they move to the clinic,” said Laia Crespo, Partner at Sanofi Ventures. “We are impressed by the… Read More

#Business & Investment #News

Gene therapy
#Cardiovascular disease #Gene editing #Genetics / genomics #In vivo #Verve Therapeutics

Single-course in vivo base editing therapy proven to lower cholesterol

A Phase Ib trial has shown low-density lipoprotein cholesterol (LDL-C) reductions up to 55% and blood PCSK9 protein reductions up to 84% after a single infusion of Verve Therapeutics’ Verve-101. The trial participants have heterozygous familial hypercholesterolemia (HeFH), a life-threatening inherited disease characterised by lifelong elevations… Read More

#News #Trending News